ArticleInvestigational new drugs2012

Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells.

Cristina Oliveras-Ferraros et al.PubMed ↗Publisher ↗

No numbers read from the abstract.